Dalbavancin (zeven), a novel glycopeptide for resistant gram-positive organisms.
作者信息
Colabella Jennifer, Chagan Larisa
出版信息
P T. 2008 Jan;33(1):42-57.
Abstract
摘要
相似文献
1
2
Review: dalbavancin--a novel lipoglycopeptide antimicrobial for gram positive pathogens.综述：达巴万星——一种用于革兰氏阳性病原体的新型脂糖肽类抗菌药物。
Pak J Pharm Sci. 2008 Jan;21(1):78-87.
3
Antimicrobial spectrum and potency of dalbavancin tested against clinical isolates from Europe and North America (2003): initial results from an international surveillance protocol.达巴万星对来自欧洲和北美的临床分离株的抗菌谱及效力（2003年）：一项国际监测方案的初步结果
J Chemother. 2005 Dec;17(6):593-600. doi: 10.1179/joc.2005.17.6.593.
4
A comparative review of the lipoglycopeptides: oritavancin, dalbavancin, and telavancin.糖肽类抗生素的比较综述：奥他万古霉素、达巴万星和替拉万星。
Pharmacotherapy. 2010 Jan;30(1):80-94. doi: 10.1592/phco.30.1.80.
5
[Antimicrobial spectrum of dalbavancin. Mechanism of action and in vitro activity against Gram-positive microorganisms].[达巴万星的抗菌谱。作用机制及对革兰氏阳性微生物的体外活性]
Enferm Infecc Microbiol Clin. 2017 Jan;35 Suppl 1:9-14. doi: 10.1016/S0213-005X(17)30029-0.
6
Worldwide assessment of dalbavancin activity and spectrum against over 6,000 clinical isolates.达巴万星对6000多株临床分离株的活性和抗菌谱的全球评估。
Diagn Microbiol Infect Dis. 2004 Feb;48(2):137-43. doi: 10.1016/j.diagmicrobio.2003.09.004.
7
Old and New Glycopeptide Antibiotics: Action and Resistance.新旧糖肽类抗生素：作用与耐药性。
Antibiotics (Basel). 2014 Nov 4;3(4):572-94. doi: 10.3390/antibiotics3040572.
8
[In vitro activity of linezolid and dalbavancin against vancomycin-resistant enterococci].利奈唑胺和达巴万星对耐万古霉素肠球菌的体外活性
Mikrobiyol Bul. 2012 Jul;46(3):359-65.
9
In vivo pharmacodynamic activity of the glycopeptide dalbavancin.糖肽类药物达巴万星的体内药效学活性。
Antimicrob Agents Chemother. 2007 May;51(5):1633-42. doi: 10.1128/AAC.01264-06. Epub 2007 Feb 16.
10
Dalbavancin and telavancin: novel lipoglycopeptides for the treatment of Gram-positive infections.达巴万星和替考拉宁：用于治疗革兰氏阳性菌感染的新型脂糖肽类药物。
Expert Rev Anti Infect Ther. 2008 Feb;6(1):67-81. doi: 10.1586/14787210.6.1.67.
本文引用的文献
1
Comparison of mortality risk associated with bacteremia due to methicillin-resistant and methicillin-susceptible Staphylococcus aureus.耐甲氧西林金黄色葡萄球菌与甲氧西林敏感金黄色葡萄球菌所致菌血症相关死亡风险的比较。
Infect Control Hosp Epidemiol. 2007 Mar;28(3):273-9. doi: 10.1086/512627. Epub 2007 Feb 15.
2
Bactericidal activity and resistance development profiling of dalbavancin.达巴万星的杀菌活性及耐药性发展概况
Antimicrob Agents Chemother. 2007 Apr;51(4):1150-4. doi: 10.1128/AAC.00620-06. Epub 2007 Jan 12.
3
Activity of dalbavancin tested against Staphylococcus spp. and beta-hemolytic Streptococcus spp. isolated from 52 geographically diverse medical centers in the United States.达巴万星针对从美国52个地理位置不同的医疗中心分离出的葡萄球菌属和β-溶血性链球菌属的活性。
J Clin Microbiol. 2007 Mar;45(3):998-1004. doi: 10.1128/JCM.02368-06. Epub 2007 Jan 10.
4
Methicillin-resistant S. aureus infections among patients in the emergency department.急诊科患者中的耐甲氧西林金黄色葡萄球菌感染
N Engl J Med. 2006 Aug 17;355(7):666-74. doi: 10.1056/NEJMoa055356.
5
In vitro activities of dalbavancin and 12 other agents against 329 aerobic and anaerobic gram-positive isolates recovered from diabetic foot infections.达巴万星及其他12种药物对从糖尿病足感染中分离出的329株需氧和厌氧革兰氏阳性菌的体外活性。
Antimicrob Agents Chemother. 2006 Aug;50(8):2875-9. doi: 10.1128/AAC.00286-06.
6
Dalbavancin: a novel lipoglycopeptide antibacterial.达巴万星：一种新型脂糖肽类抗菌药物。
Pharmacotherapy. 2006 Jul;26(7):908-18. doi: 10.1592/phco.26.7.908.
7
Dalbavancin: a new option for the treatment of gram-positive infections.达巴万星：治疗革兰氏阳性菌感染的新选择。
Ann Pharmacother. 2006 Mar;40(3):449-60. doi: 10.1345/aph.1G158. Epub 2006 Feb 28.
8
Microbiologic characterization of isolates from a dalbavancin clinical trial for catheter-related bloodstream infections.一项关于达巴万星治疗导管相关血流感染的临床试验中分离菌株的微生物学特征分析。
Diagn Microbiol Infect Dis. 2006 Feb;54(2):83-7. doi: 10.1016/j.diagmicrobio.2005.09.004.
9
Antimicrobial spectrum and potency of dalbavancin tested against clinical isolates from Europe and North America (2003): initial results from an international surveillance protocol.达巴万星对来自欧洲和北美的临床分离株的抗菌谱及效力（2003年）：一项国际监测方案的初步结果
J Chemother. 2005 Dec;17(6):593-600. doi: 10.1179/joc.2005.17.6.593.
10
Spectrum and potency of dalbavancin tested against 3322 Gram-positive cocci isolated in the United States Surveillance Program (2004).在美国监测项目（2004年）中分离出的3322株革兰氏阳性球菌上测试的达巴万星的抗菌谱和效价。
Diagn Microbiol Infect Dis. 2006 Feb;54(2):149-53. doi: 10.1016/j.diagmicrobio.2005.08.015. Epub 2006 Jan 19.
Zotero 插件